; exemption from requirements of the Drug Supply Chain Security Act. Sec. 304. Grant program on harms of drug misuse. Sec. 305. Good Samaritan immunity. Sec. 306. Report on overdose prevention centers. Sec. 307. Prisons and substance use disorder treatment. 2. Definitions In this Act: (1) Fentanyl-related substance The term fentanyl-related substance has the meaning given the term in section 1308.11(h)(30)(i) of title 21, Code of Federal Regulations (or successor regulations). (2) Secretary The term Secretary means the Secretary of Health and Human Services. I Fentanyl 101. Enhanced fentanyl surveillance (a) CDC surveillance program Part J of title III of the Public Health Service Act is amended by inserting after section 392A ( 42 U.S.C. 280b–1 ) the following: 392B. Enhanced fentanyl surveillance (a) Definition In this section, the term fentanyl-related substance has the meaning given the term in section 1308.11(h)(30)(i) of title 21, Code of Federal Regulations (or successor regulations). (b) Data collection The Director of the Centers for Disease Control and Prevention shall enhance the Overdose Data to Action program and other drug surveillance programs of the Centers for Disease Control and Prevention by— (1) encouraging States, political subdivisions of States, and territories to participate in such programs; (2) increasing and accelerating the collection of data on fentanyl, fentanyl-related substances, other synthetic opioids, and new emerging drugs of abuse (including harmful adulterants of fentanyl, such as xylazine), including the collection of related overdose data from medical examiners and drug treatment admissions and information regarding drug seizures; and (3) utilizing available and emerging information on fentanyl, fentanyl-related substances, other synthetic opioids, and new emerging drugs of abuse, including information from— (A) the High Intensity Drug Trafficking Areas program under section 707 of the Office of National Drug Control Policy Reauthorization Act of 1998